1 / 7

Daan Kromhout, et al. NEJM epub August 29, 2010

Daan Kromhout, et al. NEJM epub August 29, 2010. Screening, Randomization, and Follow-up. Daan Kromhout, et al. NEJM epub August 29, 2010. Baseline Characteristics of the Patients, According to Study Group*

kara
Download Presentation

Daan Kromhout, et al. NEJM epub August 29, 2010

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Daan Kromhout, et al. NEJM epub August 29, 2010

  2. Screening, Randomization, and Follow-up Daan Kromhout, et al. NEJM epub August 29, 2010

  3. Baseline Characteristics of the Patients, According to Study Group* *Plus–minus values are means ±SD. ALA denotes alpha-linolenic acid, DHA docosahexaenoic acid, EPA eicosapentaenoic acid, HDL high-density lipoprotein, and LDL low-density lipoprotein. † To convert the values for glucose to milligrams per deciliter, divide by 0.05551. ‡ To convert the values for cholesterol to milligrams per deciliter, divide by 0.02586. To convert the values for triglycerides to milligrams per deciliter, divide by 0.01129. § The body-mass index is the weight in kilograms divided by the square of the height in meters. Daan Kromhout, et al. NEJM epub August 29, 2010

  4. Primary and Secondary Outcomes, According to n–3 Fatty-Acid Supplementation* Daan Kromhout, et al. NEJM epub August 29, 2010

  5. Kaplan–Meier Curves for Primary and Secondary End Points Daan Kromhout, et al. NEJM epub August 29, 2010

  6. Effect of EPA–DHA Supplementation and ALA Supplementation on the Primary End Point in Subgroups of Patients Daan Kromhout, et al. NEJM epub August 29, 2010

  7. Cardiovascular Outcomes in Patients, According to the Presence or Absence of Diabetes and n–3 Fatty-Acid Supplementation Daan Kromhout, et al. NEJM epub August 29, 2010

More Related